A Bayesian adaptive design for two-stage clinical trials with survival data
From MaRDI portal
(Redirected from Publication:745979)
Recommendations
- A two-stage adaptive allocation design for survival outcome with informative censoring
- scientific article; zbMATH DE number 5183648
- A randomized two stage adaptively censored design with application to testing
- Some results on two-stage clinical trials
- On design and inference for two-stage adaptive clinical trials with dependent data
Cites work
- scientific article; zbMATH DE number 1817583 (Why is no real title available?)
- scientific article; zbMATH DE number 3152057 (Why is no real title available?)
- scientific article; zbMATH DE number 63428 (Why is no real title available?)
- scientific article; zbMATH DE number 3523004 (Why is no real title available?)
- scientific article; zbMATH DE number 3537064 (Why is no real title available?)
- scientific article; zbMATH DE number 1516975 (Why is no real title available?)
- scientific article; zbMATH DE number 1369649 (Why is no real title available?)
- scientific article; zbMATH DE number 1932870 (Why is no real title available?)
- scientific article; zbMATH DE number 3258670 (Why is no real title available?)
- A Comparison of Survival Function Estimators in the Koziol–Green Model
- A RANDOMIZED LONGITUDINAL PLAY-THE-WINNER DESIGN FOR REPEATED BINARY DATA
- A Unified Theory of Two-Stage Adaptive Designs
- A correlation goodness-of-fit test for randomly censored data
- A log gamma model and its maximum likelihood estimation
- A play-the-winner-type urn design with reduced variability
- A quick omnibus test for the proportional hazards model of random censorship
- A sequential design for maximizing the probability of a favourable response
- A simulation program for adaptive two stage designs.
- Adaptive designs for normal responses with prognostic factors
- Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches
- Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses
- Biased coin designs with a Bayesian bias
- Designed Extension of Studies Based on Conditional Power
- Distributional convergence under proportional censorship when covariables are present
- Efficient estimation of regression coefficients and baseline hazard under proportionality of conditional hazards
- Estimating the survival function under a generalized Koziol-Green model with partially informative censoring.
- Estimation of a smooth quantile function under the proportional hazards model
- Estimation of the conditional distribution in a conditional Koziol-Green model
- Investigating therapies of potentially great benefit: ECMO. With comments and a rejoinder by the author
- Maximum likelihood estimation of a survival function under the Koziol- Green proportional hazards model
- Monitoring the rates of composite events with censored data in phase II clinical trials
- Nonparametric estimation of survival functions for incomplete observations when the life time distribution is proportionally related ot the censoring time distribution
- On sample size and inference for two-stage adaptive designs
- On testing the proportionality of two cumulative incidence functions in a competing risks setup
- On the Fisher information in randomly censored data
- Optimum biased coin designs for sequential clinical trials with prognostic factors
- Quantile estimation in the proportional hazards model of random censorship
- Sequential estimation for two-stage and three-stage clinical trials
- Small-Sample Results for the Kaplan-Meier Estimator
- Some results on estimation for two—stage clinical trials
- Strong consistency under proportional censorship when covariables are present
- Strong consistency under the Koziol-Green model
- Testing to Determine the Underlying Distribution Using Randomly Censored Data
- Testing to determine the underlying distribution using incomplete observations when the life time determine is proportionally related to the censoring time distribution
- The Randomized Play-the-Winner Rule in Medical Trials
- The partial Koziol-Green model with covariates
Cited in
(22)- A multi-treatment two stage adaptive allocation for survival outcomes
- Multi-treatment covariate-adjusted adaptive design under informative censoring
- Seamlessly expanding a randomized phase II trial to phase III
- Use of bayesian analysis to design of clinical trials with one treatment
- An optimal multiarmed response adaptive design for survival outcome with independent censoring
- An optimal sequential design in ethical allocation with an adaptive interim analysis
- A multi-treatment two stage allocation design for survival outcomes with nonrandom censoring: a copula-based approach
- Some results on two-stage clinical trials
- Adaptive designs for the one-sample log-rank test
- Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers
- Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints
- A two-stage adaptive allocation design for survival outcome with informative censoring
- A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes
- Sequential and two-stage fixed-width confidence interval estimation in response-adaptive designs
- Fixed-width confidence interval for two-stage response-adaptive designs in ridit analysis
- On design and inference for two-stage adaptive clinical trials with dependent data
- Bayesian adaptive designs for clinical trials
- Bayesian two-stage design for phase II clinical trials with switching hypothesis tests
- A comparison between two treatments in a clinical trial with an ethical allocation design
- BAGS: a Bayesian adaptive group sequential trial design with subgroup-specific survival comparisons
- A randomized two stage adaptively censored design with application to testing
- Sample size formulae for two-stage randomized trials with survival outcomes
This page was built for publication: A Bayesian adaptive design for two-stage clinical trials with survival data
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q745979)
